Intermountain Health to expand stem cell collection for CAR-T cell therapy, bringing procedure to southern Utah

Loss of Y chromosome “cripples” immune cells, University of Arizona researcher finds
Cells with LOY may induce LOY in otherwise healthy cells—a finding that could explain variability in CAR T-cell therapy response

Two years ago, Dan Theodorescu made a discovery that could alter biology textbooks: The Y chromosome, widely considered to be a “functional wasteland,” has functions beyond sex determination—and in fact plays a role in cancer biology.

CAR T Vision Coalition launches with goal of doubling patients treated with the curative potential of CAR T-cell therapy by 2030

On May 30, an international coalition announced the launch of CAR T Vision, a coalition that aims to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy.

May 30, 2025

Vol.51 No.21

In Brief

KU Cancer Center breaks ground for new complex

The University of Kansas Cancer Center broke ground on the future site of a new complex on May 22 that will bring research and patient care into one area for the first time in KU Cancer Center’s history.

May 30, 2025

Vol.51 No.21

Rewriting the rules of cancer treatment one nanobody at a time

I joined Translational Genomics Research Institute, part of City of Hope, late last year to launch the Center for Accelerated Nanotherapeutics.

USC team develops analytical tool to advance CAR T-cell therapy research

A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen receptor T cells, including how they evolve during manufacturing and which ones are most effective at killing cancer.

May 02, 2025

Vol.51 No.17

In Brief

Owen Witte awarded International Harrington Prize for Innovation in Medicine

The Harrington Discovery Institute at University Hospitals and the American Society for Clinical Investigation have awarded Owen Witte with the twelfth annual Harrington Prize for Innovation in Medicine.

March 21, 2025

Vol.51 No.11

Intermountain Health to expand stem cell collection for CAR-T cell therapy, bringing procedure to southern Utah

YOU MAY BE INTERESTED IN

Loss of Y chromosome “cripples” immune cells, University of Arizona researcher finds
Cells with LOY may induce LOY in otherwise healthy cells—a finding that could explain variability in CAR T-cell therapy response

CAR T Vision Coalition launches with goal of doubling patients treated with the curative potential of CAR T-cell therapy by 2030

KU Cancer Center breaks ground for new complex

Rewriting the rules of cancer treatment one nanobody at a time

USC team develops analytical tool to advance CAR T-cell therapy research

Owen Witte awarded International Harrington Prize for Innovation in Medicine

Renew today!

Subscriber content

Never miss an issue!

Login

Intermountain Health to expand stem cell collection for CAR-T cell therapy, bringing procedure to southern Utah

YOU MAY BE INTERESTED IN

Loss of Y chromosome “cripples” immune cells, University of Arizona researcher findsCells with LOY may induce LOY in otherwise healthy cells—a finding that could explain variability in CAR T-cell therapy response

CAR T Vision Coalition launches with goal of doubling patients treated with the curative potential of CAR T-cell therapy by 2030

KU Cancer Center breaks ground for new complex

Rewriting the rules of cancer treatment one nanobody at a time

USC team develops analytical tool to advance CAR T-cell therapy research

Owen Witte awarded International Harrington Prize for Innovation in Medicine

Never miss an issue!

Login

Loss of Y chromosome “cripples” immune cells, University of Arizona researcher finds
Cells with LOY may induce LOY in otherwise healthy cells—a finding that could explain variability in CAR T-cell therapy response